小児で定期接種になり、日本でも根絶に向かうB型肝炎ウイルス
小児と成人では接種ルートが違いますのでご注意ください。
本邦では皮下注・筋注が認められておりますが、陽転率で10-30%の差があるため海外では、筋注以外の接種法は無効です。
UPTODATE
HepB vaccines are administered intramuscularly (IM) [49]. HepB vaccine administered by any route other than IM should not be counted as valid and should be repeated
Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response
Scand J Infect Dis. 1987;19(6):617-21.
The trial was performed in 58 healthy volunteers 20-43 (mean 30) years old. No statistically significant difference in seroconversion rate was observed when the intradermal (i.d.) (2 micrograms) and intramuscular (i.m.) (20 micrograms) routes were compared (100% and 96% seroconversion, respectively). The 2 microgram dose administered subcutaneously gave a seroconversion rate of only 63%(皮下注).
The importance of injecting vaccines into muscle
BMJ. 2000 Nov 18; 321(7271): 1237–1238.
Compared with intramuscular administration, subcutaneous injection of hepatitis B vaccine leads to significantly lower seroconversion rates and more rapid decay of antibody response
支持論文:
1) Poland GA, Borrud A, Jacobson RM, McDermott K, Wollan PC, Brakke D, et al. Determination of deltoid fat pad thickness: implications for needle length in adult immunization. JAMA. 1997;277:1709–1711
2) Shaw FE, Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7:425–430
小児と成人では接種ルートが違いますのでご注意ください。
本邦では皮下注・筋注が認められておりますが、陽転率で10-30%の差があるため海外では、筋注以外の接種法は無効です。
UPTODATE
HepB vaccines are administered intramuscularly (IM) [49]. HepB vaccine administered by any route other than IM should not be counted as valid and should be repeated
Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response
Scand J Infect Dis. 1987;19(6):617-21.
The trial was performed in 58 healthy volunteers 20-43 (mean 30) years old. No statistically significant difference in seroconversion rate was observed when the intradermal (i.d.) (2 micrograms) and intramuscular (i.m.) (20 micrograms) routes were compared (100% and 96% seroconversion, respectively). The 2 microgram dose administered subcutaneously gave a seroconversion rate of only 63%(皮下注).
The importance of injecting vaccines into muscle
BMJ. 2000 Nov 18; 321(7271): 1237–1238.
Compared with intramuscular administration, subcutaneous injection of hepatitis B vaccine leads to significantly lower seroconversion rates and more rapid decay of antibody response
支持論文:
1) Poland GA, Borrud A, Jacobson RM, McDermott K, Wollan PC, Brakke D, et al. Determination of deltoid fat pad thickness: implications for needle length in adult immunization. JAMA. 1997;277:1709–1711
2) Shaw FE, Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7:425–430
※コメント投稿者のブログIDはブログ作成者のみに通知されます